Roche (RHHBY)
Health Care · Pharma & Biotech · Switzerland
$61.27
+0.82%
About
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. Roche Holding AG has a collaboration agreement with Excalipoint Therapeutics to evaluate EXP011 in DLL3-expressing solid tumors. The company was founded in 1896 and is based in Basel, Switzerland.
Source: Yahoo Finance
Sector
Healthcare
Website
www.roche.comIndex Benchmarks
| Period | RHHBY | Dow Jones | Nasdaq | S&P 500 |
|---|---|---|---|---|
| 1D | +0.82% | -1.09%(+1.9) | -2.86%(+3.7) | -1.82%(+2.6) |
| 1W | +0.16% | -0.85%(+1.0) | -2.00%(+2.2) | -0.57%(+0.7) |
| 1M | +17.04% | +1.66%(+15.4) | -5.34%(+22.4) | -1.13%(+18.2) |
| YTD | +19.09% | +7.00%(+12.1) | +9.47%(+9.6) | +10.52%(+8.6) |
| 1Y | +51.66% | +8.85%(+42.8) | +7.22%(+44.4) | +10.82%(+40.8) |
Numbers in parentheses show out/underperformance vs the index
Previous Close$60.77
Open$61.10
Day's Range$60.79 - $61.43
52 Week Range$40.07 - $61.49
Volume202K
Avg. Volume1.78M
Market Cap$394B
Beta (5Y)0.33
P/E Ratio26.3x
EPS$2.41
P/B Ratio9.93x
Dividend Yield2.63%
Revenue$76B
Net Income$15B
Operating Margin28.3%
Total Debt$39B
Cash$12B
1y Target Est$60.01